Human recombinant relaxin reduces heart injury and improves ventricular performance in a swine model of acute myocardial infarction

Annals of the New York Academy of Sciences

Volumn 1041, Issue , 2005, Pages 431-433

  Perna, Avio Maria ^a   Masini, Emanuela ^b   Nistri, Silvia ^b   Sacchi, Tatiana Bani ^b   Bigazzi, Mario ^c   Bani, Daniele ^b,d  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Prosperius Institute   (Italy)

^d Histology and Forensic Medicine ^*  (Italy)

Author keywords

Cardioprotection; Ischemia; Myocardial infarction; Reperfusion

Indexed keywords

CREATINE KINASE MB; HUMAN RECOMBINANT RELAXIN; INOTROPIC AGENT; MYOGLOBIN; RELAXIN; TROPONIN T; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL DAMAGE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE MARKER; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; HEART INDEX; HEART INJURY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE PERFORMANCE; HISTOPATHOLOGY; NONHUMAN; SWINE; TRANSLUMINAL CORONARY ANGIOPLASTY;

SUS SCROFA;

EID: 23644446891     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1282.064     Document Type: Conference Paper

References (9)

1. DSCHIETZIG, T. & K. STANGL. 2002. Relaxin: a pregnancy hormone as a central player of body fluid and circulation homeostasis. Cell. Mol. Life Sci. 59: 1-13.
2. HSU, S.Y., K. NAKABAYASHI, S. NISHI, et al. 2002. Activation of orphan receptors by the hormone relaxin. Science 295: 671-673.
3. BANI, D. 1997. Relaxin, a pleiotropic hormone. Gen. Pharmacol. 28: 13-22.
4. SHERWOOD, O.D. 2004. Relaxin's physiological roles and other diverse actions. Endocr. Rev. 25: 205-234.
5. MASINI, E., D. BANI, M.G. BELLO, et al. 1997. Relaxin counteracts myocardial damage induced by ischemia-reperfusion in isolated guinea pig hearts: evidence for an involvement of nitric oxide. Endocrinology 138: 4713-4720.
6. BANI, D., E. MASINI, M.G. BELLO, et al. 1998. Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart. Am. J. Pathol. 152: 1367-1376.
7. SEIBOLD, J.R., P.J. CLEMENTS, D.E. FURST, et al. 1998. Safety and pharmacokinetics of recombinant human relaxin in systemic sclerosis. J. Rheumatol. 25: 302-307.
8. KEELEY, E.G., J.A. BOURA & C.L. GRINES. 2003. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361: 13-20.
9. O'NEILL, W.W. & S.R. DIXON. 2004. The year in interventional cardiology. J. Am. Coll. Cardiol. 43: 875-890.